A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Participants
Clinical trial NCT07345364 · RECRUITING
Trial details
- NCT number
- NCT07345364
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-12
- Primary completion
- 2026-07-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.